Filing metadata

Accession number
0001140361-23-051263
Form type
Form 4
Filer
Eiger BioPharmaceuticals, Inc.
CIK
CIK 1305253
Filed
Nov 02, 2023
Reporting period
Oct 31, 2023
Description
Insider transaction

Explore SEC Filings Hub